MedTrace Logo

Fluocinolone Acetonide Intravitreal Inserts for Vein Occlusion in Retina

NCT00770770 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2015-05-28

Study results available
· View outcomes & findings →

Summary

This study will assess the safety and efficacy of FA Intravitreal Inserts in subjects with macular edema secondary to RVO.

Conditions

  • Macular Edema
  • Retinal Vein Occlusion

Interventions

DRUG

Fluocinolone Acetonide

0.2 µg/day

DRUG

Fluocinolone Acetonide

0.5 µg/day

Sponsors & Collaborators

  • Alimera Sciences

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2013-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00770770 on ClinicalTrials.gov